FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Delavirdine Mesylate (RESCRIPTOR) Tablets
Status: Discontinuation
»Therapeutic Categories: Antiviral

ViiV Healthcare (New 06/26/2019)

Company Contact Information:

Presentation Posting Date Related Information
200 mg tablets; bottles of 180 tablets (NDC 49702-225-17) 06/26/2019 This decision is business-related and the anticipated final date for availability to patients is January 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English